Summary:
Pre transplant screening work-up of donors for allogeneic blood and marrow transplantation is essential in an effort to minimize risks to the recipient and protect the donor. At Princess Margaret Hospital, every potential donor is screened with a bone marrow aspirate. The case histories of three asymptomatic potential donors who presented within 1 year with normal complete blood counts, history and physical examination are presented. A 65-year-old male patient was diagnosed with smouldering multiple myeloma, a 72-year-old male patient with chronic lymphocytic leukemia and a 42-year-old male patient with myelodysplastic syndrome. Bone marrow examination led to the diagnosis in each one of these cases. Of note is that each of the potential donors was discovered to have the same disease as the transplant recipient. In vitro clonogenic hemopoietic progenitor assays were compared to those of 20 normal volunteers. Inferior growth of hemopoietic progenitor colonies in all three was noted. In conclusion, particularly in older donors and donors with potential for familial malignancies, more screening investigations including bone marrow aspiration may be reasonable to investigate for occult hematological malignancies prior to stem cell donation. Clonogenic assays can contribute to detect hemopoietic abnormalities pre transplant.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Buckner CD, Clift RA, Sanders JE et al. Marrow harvesting from normal donors. Blood 1984; 64: 630–634.
Horowitz MM, Loberiza FR, Bredeson C et al. Transplant registries: guiding clinical decisions and improving outcomes. Oncology 2001; 15: 649–659.
Messner HA, Jamal N . Cell culture assessment of hematopoietic progenitors in bone marrow transplantation. J Hematother 1993; 2: 19–25.
Messner HA, Curtis JE, Minden MD et al. Clonogenic hemopoietic precursors in bone marrow transplantation. Blood 1987; 70: 1425–1432.
Bahn AK . Difference between two independent sample means. In: Basic Medical Statistics. Grune & Stratton Inc.: NewYork, 1972, pp 136–143.
Niederwieser DW, Appelbaum FR, Gastl G et al. Inadvertent transmission of a donors acute myeloid leukemia in bone marrow transplantation for chronic myeloid leukemia. N Engl J Med 1990; 322: 1794–1796.
Peters SO, Stockschlaeder M, Zeller W et al. Monoclonal gammopathy of unknown significance in a bone marrow donor. Ann Hematol 1993; 66: 93–95.
Gratwohl A, Corny P, Speck B . Bone marrow transplantation from a donor with Gauchers disease. Transplantation 1979; 28: 266.
Lowsky R, Fyles G, Minden M et al. Detection of donor cell derived acute myelogenous leukemia in a patient transplanted for chronic myelogenous leukemia using fluorescence in situ hybridization. Br J Hematol 1996; 93: 163–165.
Grosbois B, Jego P, Attal M et al. Familial multiple myeloma: report of fifteen families. Br J Haematol 1999; 105: 768–770.
Mandla SG, Goobie S, Kumar RT et al. Genetic analysis of familial myelodysplastic syndrome: absence of linkage to chromosomes 5q31 and 7 q22. Cancer Genet Cytogenet 1998; 105: 113–118.
Paltiel O, Schmit T, Adler B et al. The incidence of lymphoma in first degree relatives of patients with Hodgkin's disease and Non Hodgkin's lymphoma: results and limitations of a registry linked study. Cancer 2000; 88: 2357–2366.
Acknowledgements
We thank Dr Jean Pierre Moquin, Sacre Coeur Hospital, University of Montreal, for critical review of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kiss, T., Chang, H., Daly, A. et al. Bone marrow aspirates as part of routine donor assessment for allogeneic blood and marrow transplantation can reveal presence of occult hematological malignancies in otherwise asymptomatic individuals. Bone Marrow Transplant 33, 855–858 (2004). https://doi.org/10.1038/sj.bmt.1704430
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704430
Keywords
This article is cited by
-
Influence of the degree of donor bone marrow hyperplasia on patient clinical outcomes after allogeneic hematopoietic stem cell transplantation
Science China Life Sciences (2020)
-
Sixty as the new forty: considerations on older related stem cell donors
Bone Marrow Transplantation (2017)
-
Risks and Mechanisms of Oncological Disease Following Stem Cell Transplantation
Stem Cell Reviews and Reports (2010)
-
Genetically identical twin transplantation for chronic lymphocytic leukemia
Leukemia (2007)
-
Long-term donor health and its relationship with outcome of allogeneic hematopoietic stem cell transplantation
Bone Marrow Transplantation (2006)